Chronic Asymptomatic Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in the Immunocompromised Patient: New Challenges and Urgent Needs

Lorenzo Lodi^{1

2}, Maria Moriondo², Alessandra Pucci¹, Laura Pisano², Silvia Ricci^{1

2}, Giuseppe Indolfi^{3

4}, Chiara Azzari^{1

2}

Affiliations

¹ Department of Health Sciences, University of Florence and Meyer Children's University Hospital, Florence, Italy.
² Immunology and Molecular Microbiology Unit, Meyer Children's University Hospital, Florence, Italy.
³ Department of Pediatrics, Meyer Children's University Hospital, Florence, Italy.
⁴ NEUROFARBA Department, University of Florence, Florence, Italy.

Comment

Lorenzo Lodi et al. Clin Infect Dis. 2022.

. 2022 Feb 11;74(3):553.

doi: 10.1093/cid/ciab538.

Lorenzo Lodi^{1

2}, Maria Moriondo², Alessandra Pucci¹, Laura Pisano², Silvia Ricci^{1

2}, Giuseppe Indolfi^{3

4}, Chiara Azzari^{1

2}

¹ Department of Health Sciences, University of Florence and Meyer Children's University Hospital, Florence, Italy.
² Immunology and Molecular Microbiology Unit, Meyer Children's University Hospital, Florence, Italy.
³ Department of Pediatrics, Meyer Children's University Hospital, Florence, Italy.
⁴ NEUROFARBA Department, University of Florence, Florence, Italy.

No abstract available

Comment on

Improving the Outcomes of Immunocompromised Patients With Coronavirus Disease 2019.
Haidar G, Mellors JW. Haidar G, et al. Clin Infect Dis. 2021 Sep 15;73(6):e1397-e1401. doi: 10.1093/cid/ciab397. Clin Infect Dis. 2021. PMID: 33949644 Free PMC article.